Corporate
Email this page
closeSmith & Nephew announces timing of first quarter results
9 April 2009
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will be announcing its results for the first quarter ending 28 March 2009 on Thursday 30 April 2009 at 7am BST/2.00am Eastern. This will be followed by a conference call with financial analysts at 8.30am BST/3.30am Eastern, which can be heard live via webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
About Us
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were $3.8 billion.
Enquiries
| Investors/Analysts | |
| Julie Allen | Tel: +44 (0)20 7401 7646 |
| Corporate Affairs Co-ordinator | |
| Smith & Nephew plc | |
| Media | |
| Jon Coles | +44 (0) 20 7404 5959 |
| Brunswick – London | |
| Cindy Leggett-Flynn | +1 (212) 333 3810 |
| Brunswick – New York |